| Salvage Immunotherapy and Chemotherapy in Esophageal Squamous Cell Carcinoma Patients Nonresponding to Initial Neoadjuvant Chemoradiotherapy (NCT05103501) | Shanghai Chest Hospital | 2021-12-01 |
| Adjunctive Right Atrial Ablation for Persistent Atrial Fibrillation With Right Atrial Enlargement (NCT05227586) | Shanghai Chest Hospital | 2021-11-01 |
| Driver Ablation of Persistent Atrial Fibrillation With Severe Atrial Fibrosis. (NCT05085912) | Shanghai Chest Hospital | 2021-11-01 |
| A Study to Evaluate Pembrolizumab Plus Lenvatinib in PD-L1 Positive TKI Resistant NSCLC Patients (NCT05078931) | Shanghai Chest Hospital | 2021-10-27 |
| Furmonertinib Combined With Anlotinib as the First-line Treatment in Patients With EGFR Mutation-positive NSCLC (NCT04895930) | Shanghai Chest Hospital | 2021-10-12 |
| A Phase II Trial of Camrelizumab Combined With Famitinib for Adjuvant Treatment of Stage II-IIIA NSCLC. (NCT05005468) | Shanghai Chest Hospital | 2021-09-01 |
| Cardiac Autonomic Nerve Improvement and Pacemaker Therapy in Patients With Sinus Bradycardia (NCT05021627) | Shanghai Chest Hospital | 2021-09-01 |
| Strict Weight Management Based on GLP-1 RA for Ablation Outcomes in Overweight or Obese Patients with T2DM and AF (NCT06660134) | Shanghai Chest Hospital | 2021-08-01 |
| Termination of Persistent Atrial Fibrillation by Catheter Ablation (NCT04958928) | Shanghai Chest Hospital | 2021-08-01 |
| Anlotinib Combined With PD-1 Inhibitors for Advanced/Metastatic Esophageal Cancer (NCT04984096) | Shanghai Chest Hospital | 2021-08-01 |
| Trametinib Plus Anlotinib in Non-G12C KRAS-Mutant NSCLC Patients (NCT04967079) | Shanghai Chest Hospital | 2021-08-01 |
| Almonertinib Treats Advanced NSCLC Patients With EGFR Mutations Who Are Safety Intolerant After Osimertinib Treatment (NCT04882345) | Shanghai Chest Hospital | 2021-07-15 |
| To Evaluate the Efficacy of Afatinib in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer With NRG1 Fusion (NCT04814056) | Shanghai Chest Hospital | 2021-06-01 |
| Almonertinib Versus Osimertinib in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases (NCT04870190) | Shanghai Chest Hospital | 2021-06-01 |
| Diagnostic Value of UTB and TB for PPL (NCT04571476) | Shanghai Chest Hospital | 2021-03-08 |
| The Efficacy and Safety of TBCB vs TBFB in Diagnosis of GGO (NCT04727190) | Shanghai Chest Hospital | 2021-03-01 |
| Dacomitinib in Lung Cancer With Uncommon EGFR Mutations (NCT04504071) | Shanghai Chest Hospital | 2020-12-08 |
| Rh-Endostatin Combined With CCRT(50 Gy) Followed by Durvalumab Maintenance for the Treatment of Specific Phase III NSCLC (NCT04613284) | Shanghai Chest Hospital | 2020-12-01 |
| Advanced Lung Tumor Treated by Osimertinib Plus Anlotinib (NCT04770688) | Shanghai Chest Hospital | 2020-11-19 |
| Nivolumab Combined With Anlotinib as Re-challenge Treatment in Advanced NSCLC (NCT04507906) | Shanghai Chest Hospital | 2020-11-02 |
| NGS-based Comprehensive Genomic ctDNA Panel in NSCLC With Immunotherapy (NCT04636047) | Shanghai Chest Hospital | 2020-11-01 |
| Cardiac Adverse Reactions Related to Immune Checkpoint Inhibitor in NSCLC Patients (NCT04473703) | Shanghai Chest Hospital | 2020-08-01 |
| The Chinese Registration Study of Driver Ablation of Persistent Atrial Fibrillation. (NCT04489004) | Shanghai Chest Hospital | 2020-08-01 |
| ENB-guided Ablation Therapy Combined With VATS in the Treatment of MPLC (NCT04730453) | Shanghai Chest Hospital | 2020-07-24 |
| Tislelizumab Combined With Chemotherapy With or Without Bevacizumab in TKI-Resistant EGFR-Mutated Non-squamous NSCLC (NCT04405674) | Shanghai Chest Hospital | 2020-07-15 |
| AF Ablation for HF With Reduced EF (NCT05827172) | Shanghai Chest Hospital | 2020-06-01 |
| Clinical Study of ctDNA and Exosome Combined Detection to Identify Benign and Malignant Pulmonary Nodules (NCT04182893) | Shanghai Chest Hospital | 2019-10-08 |
| Combination Therapy of Sintilimab and Anlotinib as a First-line Treatment in Advanced NSCLC (SUNRISE) (NCT04124731) | Shanghai Chest Hospital | 2019-10-01 |
| Comparison of Esophagectomy and Chemoradiation for Patients With cN0-pT1b Stage Esophageal Squamous Cell Carcinoma (NCT04135664) | Shanghai Chest Hospital | 2019-09-01 |
| NGS-based Large-panel in Targeted Drug Delivery and Immunotherapy of Lung Cancer (NCT04159337) | Shanghai Chest Hospital | 2019-08-30 |
| Pre-Surgery If Needed for Oesophageal Cancer (NCT03937362) | Shanghai Chest Hospital | 2019-08-08 |
| KN046 in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma (NCT03927495) | Shanghai Chest Hospital | 2019-05-22 |
| Anlotinib Plus Etoposide and Carboplatin as First-line Treatment for Extensive-stage Small Cell Lung Cancer (NCT04684017) | Shanghai Chest Hospital | 2019-05-01 |
| Apatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer (NCT03913182) | Shanghai Chest Hospital | 2019-04-02 |
| ENB for the Diagnosis of PPNs:a Real World Study (NCT03716284) | Shanghai Chest Hospital | 2019-03-20 |
| Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations (NCT05701787) | Shanghai Chest Hospital | 2019-01-01 |
| Electromagnetic Navigation Versus CT Guided TTNA in the Diagnosis of Early Peripheral Lung Cancer (NCT03802266) | Shanghai Chest Hospital | 2019-01-01 |
| To Evaluate the Efficacy of Afatinib in Advanced Lung Squamous Cell Carcinoma With EGFR Sensitive Mutation (NCT04132102) | Shanghai Chest Hospital | 2018-11-27 |
| China Lung Cancer Screening (CLUS) Study Version 2.0 (NCT03975504) | Shanghai Chest Hospital | 2018-08-01 |
| First-line Combination Treatment Based on Anlotinib (NCT03628521) | Shanghai Chest Hospital | 2018-07-20 |
| ENB in the Diagnosis of Peripheral Pulmonary Nodules (NCT03569306) | Shanghai Chest Hospital | 2018-07-04 |
| Intraoperative Ultrasonographic Localization of Pulmonary Nodules in VATS (NCT03599505) | Shanghai Chest Hospital | 2018-07-01 |
| EBUS Image Features in the Diagnosis of PPLs (NCT03575715) | Shanghai Chest Hospital | 2018-07-01 |
| Prediction Model of CP-EBUS in the Diagnosis of Lymph Nodes (NCT04328792) | Shanghai Chest Hospital | 2018-07-01 |
| Prediction Model of Peripheral Pulmonary Lesions Based on R-EBUS Image (NCT04497233) | Shanghai Chest Hospital | 2018-07-01 |
| A Prospective Study to Evaluate the Consistency of Next-Generation Sequencing(NGS)-Panels by Using Malignant Hydrothorax Form NSCLC (NCT03546452) | Shanghai Chest Hospital | 2018-05-18 |
| ENB Guided MWA for Early-stage Peripheral Lung Cancer (NCT04005157) | Shanghai Chest Hospital | 2018-04-18 |
| Transbronchial Ablation for Peripheral Lung Tumor (NCT02972177) | Shanghai Chest Hospital | 2018-02-07 |
| Hypofractionated vs. Conventionally Fractionated Concurrent CRT for Unresectable Stage III NSCLC (NCT03331575) | Shanghai Chest Hospital | 2017-11-01 |
| Analysis of Re-biopsy Specimens in Advanced NSCLC With Acquired Resistance of EGFR-TKI Targeted Therapy (NCT03309462) | Shanghai Chest Hospital | 2017-09-01 |